USPTO serial 78370484
PABVEC
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- SALEMI, DOMINICK
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with PABVEC?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
D-93053 REGENSBURG, DE
D-93053 REGENSBURG, DE
D-93053 Regensburg, DE
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Bacteria for use in food manufacture, waste water treatment, fermentation, pharmaceutical research, manufacture of cosmetics, manufacture of scientific compounds, and manufacture of pharmaceutical compounds; bacteriological preparations for use in food manufacture, waste water treatment, fermentation, pharmaceutical research, manufacture of cosmetics, manufacture of scientific compounds, and manufacture of pharmaceutical compounds; micro-organism cultures for use in food manufacture, waste water treatment, fermentation, pharmaceutical research, manufacture of cosmetics, manufacture of scientific compounds, and manufacture of pharmaceutical compounds; biochemical catalysts for use in food manufacture, waste water treatment, fermentation, pharmaceutical research, manufacture of cosmetics, manufacture of scientific compounds, and manufacture of pharmaceutical compounds; biological preparations for clinical, research and medical laboratory use, namely proteins, DNA, RNA and modifications thereof; diagnostic preparations for research use, namely proteins, DNA, RNA and modifications thereof; and enzymes and enzyme preparations for use in the field of food manufacture, waste water treatment, fermentation, pharmaceutical research, manufacture of cosmetics, manufacture of scientific compounds, and manufacture of pharmaceutical compounds | ACTIVE | — |
| 005 | Medicines for human medical purposes, namely, antibiotics, antibodies, DNA, RNA, vaccines, blood-producing preparations, hormones and enzymes, for use in the treatment of cancer, diabetes, Alzheimer's disease and infectious diseases; medicines for dental purposes, namely, antibiotics, antibodies, DNA, RNA, vaccines, blood-producing preparations, hormones and enzymes, for use in the treatment of cancer, diabetes, Alzheimer's disease and infectious diseases; medicines for veterinary purposes, namely, antibiotics, antibodies, DNA, RNA, vaccines, blood-producing preparations, hormones and enzymes, for use in the treatment of cancer, diabetes, Alzheimer's disease and infectious diseases; bacteriological preparations for medical and veterinary purposes, for use in the treatment of cancer, high blood pressure, diarrhea, skin irritations, infections, diabetes, autoimmune diseases and arthritis, as well as for use in gene therapy; biological preparations for medical purposes, namely, antibiotics, antibodies, DNA, RNA, vaccines, blood-producing preparations, hormones and enzymes, for use in the treatment of cancer, diabetes, Alzheimer's disease and infectious diseases; biological preparations for veterinary purposes, namely, antibiotics, antibodies, DNA, RNA, vaccines, blood-producing preparations, hormones, and enzymes for use in the treatment of cancer, diabetes, Alzheimer's disease and infectious diseases; germicides for institutional use, and domestic uses; vermicides for institutional use, domestic use, and residential uses; fungicides for institutional use, and domestic uses; biological materials for medical diagnostic laboratories, namely, proteins, DNA, RNA and modifications thereof; diagnostic materials for clinical and medical laboratory purposes, namely proteins, DNA, RNA and modifications thereof; deoxyribonucleic acid, especially deoxyribonucleic acid comprising 80 to 150 base pairs; and genes, especially genes comprising 80 to 150 base pairs | ACTIVE | — |
| 009 | Computer terminals; computer programs for use as tools in the field of biotechnology and molecular biology; computer software to increase potency of enzymes and enzyme preparations, bacteria preparations, bacteriological preparations, micro-organism cultures, biological preparations, diagnostic preparations; computer operating programs; computer keyboards; blank magnetic data carriers; blank optical disks; data processors; computer memories; blank floppy disks; hard drives for computers; printers for use with computers; computer interfaces; laptop computers; data processors, namely, readers and scanners; computer mouse; semiconductors; computer modems; computer monitors; computer hardware; notebook computers; automatic machines, namely automatic laboratory machines used for the synthesis of deoxyribonucleic acids; and robotic machines namely for use for laboratory purposes | ACTIVE | — |
| 042 | Computer services, namely, updating of computer software for others, consulting in the field of biotechnology, designing computer software for others, maintenance of computer software for others, leasing of computer software, providing a computer database in the fields of genomics, providing a research type computer database in the fields of medicine and pharmaceuticals, computer programming for others, leasing of computers, and reconstruction of computer data for others; chemical analysis for others; research for others in the fields of bacteriology, biology, chemistry, physics, genealogy, cosmetics, engineering, and machine engineering; laboratory services for others in the fields of bacteriology and chemistry; consultation in the fields of bacteriology, biology, chemistry, physics, genealogy, engineering and machine engineering; consultation in the field of research concerning cosmetics; consultation in the field of pharmaceutical research; measuring calibration for others; development and research of new products for others; technical consultation in the field of environmental protection; technical project planning and consulting services in the fields of bacteriology, biology, chemistry, physics, genealogy, cosmetics, engineering, and machine engineering | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by GENEART AC
- Other trademarks owned by GENEART AC
- Other trademarks owned by Geneart GmbH
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 042
- Similar marks named PABVEC
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 22, 2008 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Apr 22, 2008 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Aug 21, 2007 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 18, 2007 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| May 29, 2007 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 9, 2007 | NPUB | NOTICE OF PUBLICATION | — |
| Mar 28, 2007 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Mar 28, 2007 | ALIE | ASSIGNED TO LIE | — |
| Mar 4, 2007 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 15, 2007 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 15, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 15, 2007 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 7, 2007 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Aug 30, 2006 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 30, 2006 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 30, 2006 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Aug 26, 2006 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Jul 31, 2006 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jul 21, 2006 | ALIE | ASSIGNED TO LIE | — |
| Jul 19, 2006 | ALIE | ASSIGNED TO LIE | — |
| Mar 31, 2006 | ALIE | ASSIGNED TO LIE | — |
| Mar 27, 2006 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 6, 2006 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Nov 15, 2005 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 15, 2005 | FAXX | FAX RECEIVED | — |
| Jun 10, 2005 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 10, 2005 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 2, 2005 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| May 27, 2005 | CWBP | WITHDRAWN BEFORE PUBLICATION | — |
| Mar 7, 2005 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Feb 18, 2005 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 8, 2005 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Feb 8, 2005 | ALIE | ASSIGNED TO LIE | — |
| Jan 18, 2005 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 18, 2005 | PAPER RECEIVED | — | |
| Sep 19, 2004 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 19, 2004 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 9, 2004 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 4, 2004 | NWAP | NEW APPLICATION ENTERED | — |